Citation: Ka-man Fong, Shek-yin Au, Ka-lee Lily Chan, Wing-yiu George Ng. Update on management of acute respiratory distress syndrome[J]. AIMS Medical Science, 2018, 5(2): 145-161. doi: 10.3934/medsci.2018.2.145
[1] | Bengisen Pekmen Geridonmez . RBF simulation of natural convection in a nanofluid-filled cavity. AIMS Mathematics, 2016, 1(3): 195-207. doi: 10.3934/Math.2016.3.195 |
[2] | Abdul Rauf, Nehad Ali Shah, Aqsa Mushtaq, Thongchai Botmart . Heat transport and magnetohydrodynamic hybrid micropolar ferrofluid flow over a non-linearly stretching sheet. AIMS Mathematics, 2023, 8(1): 164-193. doi: 10.3934/math.2023008 |
[3] | Abdulaziz H. Alharbi, Ahmed G. Salem . Analytical and numerical investigation of viscous fluid-filled spherical slip cavity in a spherical micropolar droplet. AIMS Mathematics, 2024, 9(6): 15097-15118. doi: 10.3934/math.2024732 |
[4] | Iqra Batool, Naim Bajcinca . Stability analysis of a multiscale model including cell-cycle dynamics and populations of quiescent and proliferating cells. AIMS Mathematics, 2023, 8(5): 12342-12372. doi: 10.3934/math.2023621 |
[5] | Geoffrey Beck, Akram Beni Hamad . Electromagnetic waves propagation in thin heterogenous coaxial cables. Comparison between 3D and 1D models. AIMS Mathematics, 2024, 9(4): 8981-9019. doi: 10.3934/math.2024438 |
[6] | Zixuan Tian, Xiaoyue Xie, Jian Shi . Bayesian quantile regression for streaming data. AIMS Mathematics, 2024, 9(9): 26114-26138. doi: 10.3934/math.20241276 |
[7] | Vanita Sharma, Satish Kumar . Caliberating length scale parameter and micropolarity on transference of Love-type waves in composite of CoFe2O4 and Aluminium-Epoxy laden with Newtonian liquid. AIMS Mathematics, 2020, 5(3): 1820-1842. doi: 10.3934/math.2020122 |
[8] | Miao Zhu, Giulio Ventura . 3D imaging technology for improvement of and application in architecturalmonitoring. AIMS Mathematics, 2018, 3(3): 426-438. doi: 10.3934/Math.2018.3.426 |
[9] | Saleh Mousa Alzahrani . Enhancing thermal performance: A numerical study of MHD double diffusive natural convection in a hybrid nanofluid-filled quadrantal enclosure. AIMS Mathematics, 2024, 9(4): 9267-9286. doi: 10.3934/math.2024451 |
[10] | Bengisen Pekmen Geridönmez . Numerical investigation of ferrofluid convection with Kelvin forces and non-Darcy effects. AIMS Mathematics, 2018, 3(1): 195-210. doi: 10.3934/Math.2018.1.195 |
Polysaccharides are a family of carbohydrates playing fundamental roles in many biological contexts. Their structure is made of sugar rings linked by glycosidic bonds and various side functions [1]. Glycosidic bonds can be relatively easily biodegraded via glycoside hydrolase enzymes whilst the side groups directly affect polymer charge density, hydration and chemical reactivity, also being responsible for the formation of secondary structures. In the presence of charges, polysaccharides may behave like polyelectrolytes with the peculiar ability to ionize in aqueous media. Ionization aids in the solubilization of the polyelectrolytes, further being responsible for its unique properties. Noteworthy, polyelectrolyte dissolution is not comparable to the dissolution of a simple salt, because do not produce ions i.e., cation/anion—with comparable size and independent mobility such as a salt in solution - but dissolving to yield a polyion and counter ions. In particular, polyions have mobility and hold a large number of charges in close proximity, so that individual charges are strongly attached to the macromolecular backbone, with short mobility within the domain of the macromolecular coil. The negative charges are generally represented by carboxylic groups (COO−) with pKa around 3-5 or sulfate groups (SO3−) with a pKa of around 0.5-1.5 [2]. Instead, positively charged groups are ammonium groups (NH 3+) with a pKa of around 7-10 [3]. This allows to self-assembly differently charged polysaccharides (see supplementary materials—Figure 1) by interactions between the negative and positive groups and by the entropic gain associated with these associations [4]. There are two main groups of polysaccharides: cellulose and all the derivatives from plant cells (i.e., alginates), or those from animal sources—i.e., chitin from the shells of shrimp and other sea crustaceans (see supplementary materials—Figure 2).
Alginate is a polyanionic polysaccharide, not toxic, biocompatible, highly hydrophilic, generally used as stabilizer, viscosifier, and gelling agent in food, textile, pharmaceutical and biotechnological industries [5,6]. They are the main structural component of marine brown algae, which confer them strength and flexibility [7], but are also present in capsular components of soil bacteria as protection from desiccation and mechanical stress [8]. Alginic acid is obtained by acid extraction from algal tissue followed by neutralization with alkali and precipitation by the addition of calcium chloride or mineral acid. It is reconverted in sodium alginate through alkali treatment. Haug, et al. have elucidated the structural constitution of alginic acid by partial acid hydrolysis, showing that chemically alginate is made by block of (1-4)-linked β-D-mannuronic acid (M) and α-L-guluronic acid (G) monomers, alternate into different form of polymers. From chemical point of view, alginate is characterized by consecutive G residues (G-block), consecutive M residues (M-block) and alternating MG residues in equal proportion (MG-blocks) [9] or unequal proportion (GGM- and MMG-blocks) [10,11], depending especially upon the organism and tissue from which it is isolated as reported by Harding, et al. As other polysaccharides, alginate is a polydispersed system and its molecular weight is characterized by a broad distribution of molecular weights as confirmed by a polydispersivity index more than 1.1 [12,13].
Smidsørdh, et al. have largely described the high affinity of alginates for alkaline multivalent cations in order Mg2+ << Ca2+ < Sr2+ < Ba2+, underlining how it selectivity increases as the content of α-L-guluronate residues into the chain, independently upon the amount of poly-mannuronate blocks [14]. This mainly influences the ionotropic gelation due to the ionic interaction of divalent cations guluronic acid blocks, thus resulting in the formation of three-dimensional network, usually described by the “egg-box” model [15,16].
Haug, et al. focused on the correlation between the chemical structure and the physical properties of alginate. They demonstrated that solubility is influenced by many parameters, among this the pH of the solution, the ionic strength of medium and the presence of gelling ions in the solvent. Indeed, over a certain value of pH, the carboxylic acid group can be deprotonated and the alginate may be dissolved fast (see supplementary materials—Figure 3). Every alginate have own pKa value depending from the chemical composition, the concentration of alginate, and the ionic strength of the solvent gel [17]. Besides, alginic acid is not completely soluble in any solvent including water, while Na-alginate is soluble in water. Increasing the pH, the Na-alginate solutions may behave in two different ways: a rapid increase of catalysts—i.e., H+ in solution—providing the precipitation of alginic acid, or a slow increase with a formation of alginic acid. Comparing precipitation curves of alginate from different sources, again Haug, et al. demonstrated that pH induced alginate precipitation may be different as a function of the polymer molecular weight. In this context, the presence of homopolymeric blocks generally promotes the formation of crystalline regions stabilized by hydrogen bond, thus corroborating mechanisms groups of alginate precipitation [18].
Ionic crosslinking is a more simple procedure to form 3D alginate networks, by the diffusion of bivalent ions i.e., calcium, Zinc—among polymer chains. Alternatively, ions just present into the alginate network, may be released in a controlled way, as a consequence of solubility changes driven by pH variation of the microenvironment [19]. In these cases, no auxiliary molecules or catalyst are required to mediate the ions interactions among the polar groups. Starting from this approach, more complex systems such as interpenetrate or semi-interpenetrate polyelectrolytes may be fabricated to more precisely control mechanical and swelling properties [20,21,22], Since ionic crosslinking alginates have very limited stability in vivo—due to ion exchange mechanisms occurring at physiological conditions—polysaccharides are also modified by chemical way to obtain polymers with improving biological properties mediated by the large extent of functional groups along their molecular chain. Several reviews have described chemical routes based on covalent crosslink to form alginate, by a classification of involved chemical groups - secondary -OH (C-2 and C-3) or -COOH (C-6) ones. In this case, different crosslinking agents may be used epichlorohydrin [18], glutaraldehyde [23], hexamethylenediisocyanate [24], adipic acid hydrazide [25], and carbodiimide strategy [26], which may variously affect mechanical and chemical properties of the ultimate alginates.
An alternative approach to modify alginates is thought oxidation reaction on hydroxyl groups at C-2 and C-3. Oxidation via periodates leads to the formation of dialdehyde in each oxidized monomer unit by the rupture of carbon-carbon bond of vicinal glycols. So, alginate derivatives result more labile, with increased degradability, hydrophobicity and easy attachment of substituents or reductive agents by reductive amination [27,28].
Reductive amination between dialdehyde and alkyl amine needs reducing agents like sodium borohydride (NaBH4) sodium cyanoborohydride (NaCNBH4). With this method is possible to introduce long alkyl chains to the alginates achieve new alginate-derived polymeric surfactant with amphiphilic properties. Kang, et al. synthesized a series of alginate-derived polymeric surfactants (APSs) with a linear alkyl group (C8, C12, C16) by oxidation followed by reductive amination of 2,3-dialdehydic alginate [29,30]. By this method Laurienzo, et al. prepared sodium alginate grafted with low molecular weight polyethylene glycol (PEG), a promising candidate for any application in which alginate gels with higher biocompatibility and pores dimension are required, as for gel entrapment devices and microencapsulation techniques [31].
Hydroxyl sites of alginates can also undergo to a series of reactions like acetylation, phosphorylation, sulfation. Bræk, et al. showed that a moderate increase of degree of acetylation of alginate causes an expansion of the molecular chain whereas a higher degree of acetylation generates more flexible polymers increasing swelling ability [32]. Coleman, et al. prepared phosphorylated alginate hydrogels using a heterogeneous urea/phosphate reaction, which enhanced resistance to degradation [33]. Freman, et al. prepared sulfated alginate scaffold characterized by high blood compatibility and anticoagulant activity [34]. In addition, graft reaction of hydroxyl group of alginate may be optimized to increase swelling, metal ion uptake, flocculation and degradation times [35]. A very simple method to chemically modify alginate is the esterification of carboxylic groups, by the reaction of several alcohols and alkyl halides in presence of catalysts [36]. Yang, et al. have grafted fatty alcohols (octanol, dodecanol or hexadecanol) to form novel amphiphilic alginate esters (Alg-C8, Alg-C12 or Alg-C16), useful as protein drugs and a carrier of hydrophobic drugs [37]. Mahou, et al. have synthesized alginate-poly(ethylene glycol) hybrid microspheres, by the esterification of sodium alginate with vinyl sulfone-terminated multi-arm PEG (PEG-VS) directly into cell culture medium, for the transplantation of microencapsulated living cells [38]. Moreover, Jindal, et al. synthesized sodium alginate-cysteine conjugated by carbodiimides, obtaining thiolate residues with more efficient controlled drug release, mucoadhesiveness, swelling behavior and cohesivity [39,40]. Amidation of carboxylic groups with amine containing molecules have been alternatively proposed to form more hydrophilic derivatives for nucleus pulposus replacement in tissue engineering [41], or amphiphilic derivatives [42]. Lastly, alginate based hydrogels of alginate ca be also crosslinked by photo-irradiation, a less invasive strategy based on the controlled exposure to ultraviolet (UV) light to rapidly crosslink polymer chains in physiological conditions in situ [43].
Chitosan is a natural polymer obtained from chitin partially deacetylation, made from alternating monomers of 2-acetamido-2-deoxy-β-D-glucopyranose (GlcNAc; A) and 2-amino-2-deoxy-β-D-glucopyranose (GlcN; D) [44]. Deacetylation can be performed in acid, alkaline condition [45] or by chitin deacetylases. In the first case, the acid condition causes not only deacetylation of acetamido-groups of chitin, but also hydrolysis of β-glycosidic linkage with a consequent severe degradation of the polysaccharide. In the second case, the drastic alkaline condition (15-20 M NaOH at 100-120 °C) is able to deacetylate the acetamido-groups no hydrolyzing the β-glycosidic linkage. Zhao, et al. characterized the existing classes of deacetylases, demonstrating that the deacetylases recognize a sequence of four GlcNAc units in the substrate, one of which undergoes deacetylation: the resulting chitosan has a more regular deacetylation pattern than a chitosan treated with NaOH [45]. Deacetylated amino groups are very electronegative and can take up a proton allowing chitosan to behave as a hydrophilic polycations, with different chemical, physical, and biological properties from chitin. For example, Deacetylation degree (DA) generally influences polarity, pH, ionic strength and, ultimately, water soluble behavior [46]. Varum, et al. have demonstrated that chitosans—generally soluble at pH below 6—becomes soluble at pH ranging from 4 to 9 for Da = 0.60, or at pH from 6 to 7.5 for lower DA (see supplementary materials—Figure 3) [47]. Moreover, molecular weight and polydispersivity index controlled by several methods as acid hydrolysis (HCl, HNO2), free radicals (H2O2, K2S2O8), radiation (UV, γ-rays), microwaves, and thermal treatment [48], may drastically affect the polymer viscosity, mainly in the presence electrolytes [49].
Positive charge of chitosan allows forming complexes with different ions, i.e., transition metal and post-transition ions as a funtion of their selectivity Cu > Hg > Zn > Cd > Ni > Co = Ca [50] in order to obtain a non-toxic flocculent or chelating agents for the removal of heavy and reactive metals from industrial waste water [51].
Wang, et al. focused on the pKa of chitosan with different DA and molecular weight demonstrated that a slightly decreasing from 6.51 to 6.39 is possible when MW changing from 1370 to 60 kDa, while a increasing from 6.17 to 6.51 is obtained when DA decreasing from 94.6 to 73.3% [52]. Water solubility also depends from the ionic concentration, and a salting-out effect may be observed in excess of HCl (1 M HCl), making possible to prepare the chlorhydrate form of chitosan, which is soluble in water giving an acid solution with pKa 6 ± 0.1 [49]. In this context, several studies performed by IR [53], UV [54], 1H-NMR [55], 13C-NMR [56], 15N-NMR [57] studies have been demonstrated a relevant contribution of spatial distribution of acetyl groups, inter-chain H-bonding and hydrophobic properties of acetyl groups on solubility and, ultimately, on enzymes diffusion trough the chitosan network at physiological pH, and their significant outcomes in terms of biological response.
Chitosan has two types of reactive groups, the free amino groups on deacetylated units, and two hydroxyl groups on C-3 and C-6. Sreenivas and Pai, in their review, showed all the chemical modification, via derivatization with various reagents, bearing sulfhydryl functions on the chitosan, and all the properties of thiolated chitosan included the enhanced mucoadhesiveness, cohesiveness and permeation effect [58]. Jayakumar, et al. summarized different methods of preparation of sulfated chitin and chitosan and their properties, and their recent applications in various fields such as: cardio-vascular (as blood anticoagulant and hemagglutination inhibitor), antimicrobial, adsorbing metal ions, biomedical and drug delivery [59,60]. Sashiwa, et al. reported the successful preparation of water soluble chitosan derivatives by simple N,O-acetylation in MeSO3H as solvent useful to induce a hydrophobic nature to hydrophilic chitosan backbone and prevent particle aggregation [61].
Many chemical modifications have been studied to make the solubility and the positive charge of chitosan independent from the pH. Jayakumar, et al. introduced phosphonic acid or phosphanate onto chitosan, by reaction of phosphorylating agent onto the amino groups, obtaining phosphorylated-chitosans which are known to have enhanced chelating properties and water solubility [62,63]. Quaternization of primary amine of deacetylated glucosamine also increases the solubility of chitosan in water in a large range of pH. Rúnarsson, et al. developed a novel “one pot” N-selective synthesis procedure to obtain N-trimethylated chitosan chloride (TMC) [60], one of the most common partially quaternized derivative of chitosan, without secondary O-methylation. The N-trimethylation of chitosan increases the mucoadhesive properties of the polysaccharide. Several studies extensively reported by Rosenthal, et al. demonstrated that the effect of chitosan on the paracellular permeability is dependent on its positive charge, but chitosan is positively charged only at pH values lower than 6.5. To overcome chitosan’s limited effectiveness as absorption enhancer at neutral and alkaline pH values as present in the small intestine, chitosan derivatives have been developed, such as trimethyl chitosan (TMC) and Mono N-carboxymethyl chitosan (MCC), which had comparable effects on the TJs [64,65]. As widely reported by Mourya, et al. carboxymethyl chitosan (CMC) has been widely studied because of its ease of synthesis, ampholytic character and possibilities of ample of applications. The carboxymethylation can be attended through reductive alkylation or direct alkylation and the substitution can affect the hydroxyl or the amine group [66]. This modification can change not only properties such as viscosity, flocculation, chelation [67] but also biological properties as modulation of cell functioning and activities as antioxidant, antibacterial and anti-apoptotic [68]. This derivative may be properly used in sustained or controlled release drug delivery, pH responsive drug delivery, DNA delivery and as permeation enhancer too [69,71].
An easy and common strategy to improve thermal stability, swelling ratio and mechanical strength of chitosan is the use of a crosslinker agents like glutaraldehyde, oxalic acid, formaldehyde, glyoxal and genipin [72]. Metallic anions, sulfate, citrate, and phosphate-bearing groups, such as β-glycerophosphate and tripolyphosphate (TPP), may react with Chitosans to form derivatives well tolerate and biocompatible, useful in drug delivery. The main disadvantages of ionic crosslinking concern their lacks in mechanical and chemical stability, due to a highly pH-sensitive swelling [72]. Alternatively, γ-radiation and UV-light have been used to prepare graft copolymers. Cai, et al. used 60C-γ-radiation to graft N-isopropylacrilamide to fabricate pH sensitive chitosan with good swelling properties [73]. Photo-induced grafting of polyethylenglicole (PEG) on carboxymethyl chitosan has been used to to develop a pH responsive drug delivery system [74]. Yamada, et al. lso propose the use of enzymes to synthesize chitosan with unique pH-sensitive water solubility and adhesive properties [75]. Due to their cationic functions, chitosans may be successfully used to form complexes with opposite charged polymers i.e., polyanions such as alginates or proteins—with enormous potential applications in cell encapsulation, drug delivery, and tissue engineering [76].
In order to realize more efficient systems for drug delivery and the tissue engineering, with higher therapeutic effect and optimal targeting, stimulo-sensitive polymers have to be used. Environmental stimuli may be classified as follows:
- Physiological stimuli such as pH, enzymatic activities, redox potential, and glucose concentration;
- External stimuli like temperature, light, magnetic field and mechanical force [77].
Besides, the design of stimuli responsive systems requires a more accurate control of degradation rates of polysaccharides, occurring via cleavage of the glycosidic bonds and polysaccharide depolymerization, by the fine definition of reactants concentration and synthesis temperature. Hence, it is mandatory to properly understand the mechanism of degradation of polysaccharides at physiological condition and/or in the presence of enzymatic activities.
The ability of some polysaccharides to react as a function of pH conditions represents an interesting way to direct the drug to a certain tissue or cellular compartment. For instance, the degradation of alginates is strongly dependent on the pH. Haug, et al. studied the degradation of alginate from Laminaria digitata at different values of pH. They demonstrated that alginate is stable only in a range of pH-values ranging from 5 to 10. Two different degradation mechanisms may be recognized: for pH less than 5, proton-catalyzed hydrolysis is predominant, while for pH more than 10, degradation occurs via β-alkoxy-elimination [78]. Timell described the acid hydrolysis of glycosidic bond through a mechanism of three steps: (a) protonation of the glycosidic oxygen to give conjugate acid; (b) heterolysis of conjugate acid forming a not reducing end group a carbonium-oxonium ion: and (c) rapid addition of water to the carbonium-oxonium ion, forming a reducing end group [79]. Not only H+ but also carbonate and phosphate ions could catalyzed β-elimination. Haug also showed as is possible identify the contribution of β-elimination reaction with a simple colorimetric thiobarbituric acid assay [80]. Esterified alginates are more predisposed to β-elimination compared with other types of alginates, because the esterification increases the electron-attracting effect of carbonyl group in C6 which increases the rate of removal of H-5 in the first step of the β-elimination reaction. Degradation can be significant even at pH values around neutrality because most brown algae contain varying amounts of phenolic compounds which are extracted together with the alginate and represent a contamination in most commercial alginates. This degradation effect of phenolic compounds belongs to the class of ORD reactions (Oxidative-Reductive Depolymerisation) [81].
pH has a very important effect on chitosan degradation. As reported by Holme, et al. acid hydrolysis is the primary mechanism involved in chitosan degradation even if like other polysaccharides is also influenced by several degradation mechanisms [82]. Varum, et al. demonstrated that acid catalyzed not only N-acetyl linkage but also O-glycosidic linkage hydrolysis. The rate of hydrolysis of the glycosidic linkages was found to be equal to the rate of de-N-acetylation in dilute acid, while was ten times faster in concentrated acid due to different mechanism of degradation. Furthermore they demonstrated that the acid hydrolysis of glycosidic linkages depends in particularly from the DA of chitosan, in particular the degradation increases with increasing the degree of acetylation of chitosan, indeed the acid hydrolysis is specific to cleavage of A-A and A-D glycosidic linkages, because the positive charge close to the glycosidic linkage destabilizes the hydrolysis mechanism [83]. For a chitosan with medium molecular weight, DA around 0.5, ionic strength of 0.1 M and at 60 °C have been investigated about the degradation rate as a function of pH conditions from 1 to 14: the degradation is at minimum between 3 to 10. The decrease stability at pH values less than 3 is due to the acid hydrolysis of β-glycosidic-linkage and the relative increases in the degradation at low pH will be proportionally to DA. The reaction responsible for the degradation at pH higher than 10 and above could be catalyzed from alkali hydrolysis but also oxidative-reductive degradation reaction. The rate of both reactions will be expected to increase increasing pH, however chitosan is relatively stable toward alkaline degradation [84]. As previously seen, simple covalent modifications can make chitosan resistant to acid hydrolysis in the stomach, and allow to chitosan performs its mucoadhesive and absorption properties in small intestine, that is the main absorptive region of the GIT [85].
The data suggested that acid hydrolysis and β-elimination, due to alkaline conditions, are the primary mechanisms involved in the degradation of alginate, while the chitosan degradation is mainly driven by acid hydrolysis.
In vivo, delivery systems can interact with many enzymes able to degrade them. An enzymatic activity is related to a particular compartment of organism, or the enzyme levels are up-regulated at the target site. In these cases is possible design polymeric systems that deliver drugs via specific enzymatic degradation. The enzyme-based approach is a biocompatible, but especially high sensitivity and selective method to deliver drugs: for example, the metabolic activity of colonic microflora, able to cleave glycosidic linkages of saccharides, is an attractive way for targeting drug via polysaccharides in pathological tissues (i.e., colon) [86,87].
Alginate is naturally degraded by a class of enzymes called Alginate lyases or alginate depolymerases.
Wong, et al. summarized all the characteristics e biological roles of alginate lyases. This enzymes(EC 4.2.2.-) have been isolated from several sources: marine algae, marine animals and bacteria, gram-negative and gram-positive soil bacteria, marine fungi and virus and other microorganisms, while is not present in human organisms. In marine organisms, Alginate lyase is degraded and metabolized by the cell wall of brown algae, rich of alginate, to obtain a source of carbon and energy. Alginate lyases are a group of enzymes which cleave the polymer chains via a β-elimination mechanism, and even if all lyases have the same mechanism of degradation, each enzyme is defined by its individual characteristics and its preference for the glycolytic bond connecting M and G monomers (see supplementary materials—Figure 4). They reported that most of the lyases have a preference for poly(M) substrates, although a few G-specific lyases have been identified. The majority of lyases have endo-cleaving activity, only few kinds have exolytic activity [88]. Gacesa proposed a three steps mechanism to elucidate the reaction that include (a) removal of negative charge on the carboxyl anion; (b)abstraction of the proton on C5 by a general base-catalysis; (c) transfer of electron from carboxyl group to form a double bond between C4 and C5, resulting in the β-elimination of the 4-O-glycosidic bond [89]. Alginate lyases usually are used to study the composition of alginate, but they are also involved into an innovative process of biofuel production [90].
Chitosan degrading enzymes are less abundant than chitin degrading enzymes, reflecting its minor abundance in nature. Chitosan is predominantly degraded by enzymes which hydrolyze the glucosamine-glucosamine, glucosamine-N-acetyl-glucosamine, N-acetyl-glucosamine-N-acetyl-glucosamine linkage. Lysozyme and bacterial enzymes in the colon are the main enzymes involved in chitosan degradation [91]. However three human chitinases, of the GH18 family, with enzymatic activity have been identified. As reported by FunkHouser, et al., they are: di-N-acetylchitobiase, chitotriosidase and acid mammalian chitinase, all endochitinases (EC 3.2.1.14) [92].
Moreover, lysozyme is able to hydrolyze chitin and chitosan [93], the rate of degradation is inversely related to the crystallinity, and to the chitosan degree of deacetylation. In human body lysozyme have been found in different concentration in serum (4 to 13 mg/L), tears (450 to 1230 mg/L), saliva and urine [94,95] where have an important antibacterial activity [96]. Even if human lysozyme (EC 3.2.1.17) [97] is structurally different from lysozyme usually used for in vitro test, Cohen demonstrated that have a similar activity on biodegradation of chitosan [98]. As reported in several studies in vitro and in vivo, the degrading activity of lysozyme increases with increasing chitosan Degree of Acetylation (DA), suggesting that a minimum of acetylated units had to be contained in lysozyme binding site to obtain a maximum initial degradation rates. Indeed, is largely demonstrated that lysozyme contains a hexameric binding site and hexasaccharide sequence containing 3 or more GlcNAc, while can’t act on GlcN residues or in segment with small fraction of GlcNAc [99,103]. All these is in agreement with the use of chitosan with low DA as lysozyme’s inhibitor as reported by Varum, et al. [104]. N-acetyl-beta-D-glucosaminidase or NAGase (EC 3.2.1.52), which is distributed in various tissue cells, catalyses hydrolytic release of terminal β-(1-4)-linked N-acetyl-glucosamine residues from the non-reducing ends of chito-oligosaccharides [105]. Lim, et al. used a mixture solution of lysozyme and NAGase, in vitro and in vivo, and found that in vitro degradation of chitosan was similar to in vivo, also showing a synergistic effect between the two enzymes. Chitosan is initial degraded by lysozyme to oligomers or low-molecular species, later is degraded by NAGase to monomers. Using chitosan with different DA is possible obtain carrier with different degradation time for tissue engineering application [106].
On-demand controlled drug delivery is becoming feasible by the design of stimuli-responsive systems that recognize their microenvironment and react in a dynamic way. This approach is mainly interesting in tissue engineering due to the great possibility to finely tune bioactive molecules release to dynamically match the needs to address tissue in-growth (See Table 1 and 2). The use of polysaccharides with controlled degradation rates may assure a correct matching of growth rate of tissue in order to progressively form it in the place of the scaffold—namely porous platform with controlled architecture to promote basic cell functions (i.e., adhesion, proliferation, differentiation) [107].
Chitosan application | References |
Cosmetic | [125] |
Photography | [126] |
Artificially skin | [127] |
Agriculture | [128] |
Food and nutrition | [129] |
Ophthalmology | [130, 131] |
Water engineering | [132] |
Drug delivery | |
- Hydrogel | [133] |
- Tablet | [134] |
- Tablet for controlled release | [135] |
- Microcapsule | [136] |
- Nanocapsule | [137] |
- Beades | [138] |
- Transdermal system | [139] |
Antibacterial agent | [140] |
Blood anti-coagulants | [141] |
Anti-thrombogenic and haemostatic materials | [142] |
Fat trapper | [143] |
Alginate application | References |
Cosmetic | [144] |
Food industry | [145] |
Biofuel | [146] |
Oral vaccination | [147] |
Drug delivery | [148] |
- Hydrogel | [149] |
- Floating beads | [150] |
- wound dressing | [151] |
Implantation of living cells | [152] |
Antihemostatic | [153] |
Hypocholesterolemic | [154] |
Hypoglycemic | [154] |
Anti-hypertension | [155] |
Anti-obesity | [156] |
Antitumoral | [157] |
Prophylaxy of radionuclide intoxication | [158] |
In the last years, different polysaccharides have been used to design porous scaffolds to study tissue growth in “in vitro” three-dimensional (3D) models [108,109]. For instance, Li, et al. prepared 3D scaffold of chitosan-alginate to promote proliferation of chondrocyte cells and production of collagen type II to improve cartilage repair and regeneration [110]. More recently, chitosan-alginate scaffolds have been designed to reproduce the complex 3D microenvironment of tumor, so offering a new interesting platform for the development and study of anticancer therapeutics [111,112].
In this context, environmental parameters such as pH, can support the degradation of the polymer matrix corroborating the activity of enzymes in vivo. In particular, pH can either trigger the release of molecules or promote the internalization of polymer nanoparticles into cell cytoplasm, thus compensating all the specific microenvironmental changes associated with alteration of specific enzymes (such as proteases, phospolipases or glycosidases) in pathological conditions such as ischemia, inflammatory diseases or cancer [113].
As for drug delivery, smart carriers based on polysaccharides may differently work under different pH conditions, generally exerted by in vivo microenvironment, thus protecting the active principles from gastric juices or premature metabolism, to preserve the release of loaded drug until the target site [87]. Due to the reduced alginate metabolization by specific enzymes in human, it may be combined with other phases (i.e., laponite) to form hybrid nanocarriers with pH sensitivity for the sustained release of doxorubicin for cancer inhibition. Similar approaches have been also proven for the design of drug loaded capsules for the treatment of stomach diseases (pH 1.0-3.0) [114]. Alternatively, alginates have been extensively used to design drug release systems with inhibition of molecular diffusion at the gastric level (acid pH), due to the conversion of sodium alginate into insoluble alginic acid, and a rapid release of drug at intestinal level (higher pH), ascribable to the re-conversion of alginic acid into a soluble viscous alginate [115]. In order to overcome some limitations due to the pronounced burst release of alginates, other polysaccharides may be used as coating or external shell to more efficiently control drug release rates from alginate core [116,117,118]. While chitosan ionized and solubilized at strong acid conditions of the stomach, it tend to rapidly swell, forming a ionic gel at neutral pH of the intestine - thus releasing therapeutic molecules by the polymer degradation [119,120,121]. More recently, the pH sensitive behavior of chitosan has been also capitalized to design innovative anticancer drug-delivery systems. Indeed, the slight difference of pH existing between healthy tissues (7.4) and the extracellular environment of solid tumors (6.5-7.2) is one of parameters which stimulate the abnormal activity of tumor cells, providing a more rapid deficit of both nutrients and oxygen, thus shifting towards a glycolytic metabolism. In this context, chitosan nanoparticles may be capable of varying its surface charge - switching from nearly neutral to positive one - around tumor extracellular pH to promote their internalization into cell membrane with reduced toxicity, thus remarking a great potential for cancer therapy [122]. Alternatively, chitosan scaffold containing antiangiogenic agents have been successfully used in brain cancer to achieve a site-specific controlled release system in order to overcome current limitations in drug transport through the blood-brain barrier [123]. Feng, et al. prepared pH-responsive coacervate Chitosan/alginate microcapsules for oral administration of doxorubicin (DOX) with excellent low pH tolerance to enhance the stability of the alginate core in the stomach and its rapidly release in the small intestine. As the contact time between capsule surface and small intestine mucosal increases, the absorption of DOX may enhance, whereas the use of Layer By Layer structure offers the chance to deliver multiple drugs by encapsulating different drugs, separately, in the core and layers, respectively, for combined molecular therapies [124].
The rapid evolution of biomedical application field have stimulated the research for investigation of new biocompatible materials suitable for a better control of cell/materials interaction and controlled drug release and targeting. In this context, polysaccharides have recently demonstrated to be a class of macromolecules, available from renewable sources, and characterized by a wide range of physical properties (i.e., environmental stimuli response), properly set by chemical modifications. This opens the opportunity to use polysaccharides and their derivatives to design innovative devices as “smart” delivery systems capable to release an entrapped drug in response to specific physiological stimuli, by an appropriate time and space release modalities. This will be assured by the set of network properties, finely tailored by polymer concentration, and crosslinking method (i.e., physical, chemical or both reactions) for the fabrication of semi or fully interpenetrated polymer networks able to reproduce a porous matrix suitable as scaffold for cell culture, with improved properties of molecular release. In perspective, multicomponent drug delivery systems could be developed for potential therapeutic and diagnostic applications.
This study was financially supported by POLIFARMA (PON02_3203241), REPAIR (PON01-02342) and NEWTON (FIRB-RBAP11BYNP).
The authors declare no conflict of interest.
[1] |
Wheeler AP, Bernard GR (2007) Acute lung injury and the acute respiratory distress syndrome: A clinical review. Lancet 369: 1553–1564. doi: 10.1016/S0140-6736(07)60604-7
![]() |
[2] |
Bellani G, Laffey JG, Pham T, et al. (2016) Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA 315: 788–800. doi: 10.1001/jama.2016.0291
![]() |
[3] | Ranieri VM, Rubenfeld GD, Thompson BT, et al. (2012) Acute respiratory distress syndrome: The Berlin Definition. JAMA 307: 2526–2533. |
[4] |
Bernard GR, Artigas A, Brigham KL, et al. (1994) The American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818–824. doi: 10.1164/ajrccm.149.3.7509706
![]() |
[5] |
Meade MO, Cook RJ, Guyatt GH, et al. (2000) Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndrome. Am J Respir Crit Care Med 161: 85–90. doi: 10.1164/ajrccm.161.1.9809003
![]() |
[6] | Peng JM, Qian CY, Yu XY, et al. (2017) Does training improve diagnostic accuracy and inter-rater agreement in applying the Berlin radiographic definition of acute respiratory distress syndrome? A multicenter prospective study. Crit Care 21: 12. |
[7] |
Gajic O, Dara SI, Mendez JL, et al. (2004) Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation. Crit Care Med 32: 1817–1824. doi: 10.1097/01.CCM.0000133019.52531.30
![]() |
[8] |
Anonymous (1999) International consensus conferences in intensive care medicine: Ventilator-associated Lung Injury in ARDS. Am J Respir Crit Care Med 160: 2118–2124. doi: 10.1164/ajrccm.160.6.ats16060
![]() |
[9] |
Pesenti AM (2005) The concept of "baby lung". Intensive Care Med 31: 776–784. doi: 10.1007/s00134-005-2627-z
![]() |
[10] |
Curley GF, Laffey JG, Zhang H, et al. (2016) Biotrauma and Ventilator-Induced Lung Injury: Clinical Implications. Chest 150: 1109–1117. doi: 10.1016/j.chest.2016.07.019
![]() |
[11] |
Thompson BT, Chambers RC, Liu KD (2017) Acute Respiratory Distress Syndrome. N Engl J Med 377: 562–572. doi: 10.1056/NEJMra1608077
![]() |
[12] |
Amato MB, Barbas CS, Medeiros DM, et al. (1998) Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338: 347–354. doi: 10.1056/NEJM199802053380602
![]() |
[13] |
Ards N (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342: 1301–1308. doi: 10.1056/NEJM200005043421801
![]() |
[14] |
Walkey AJ, Goligher E, Del SL, et al. (2017) Low Tidal Volume versus Non-Volume-Limited Strategies for Patients with Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis. Ann Am Thorac Soc 14: S271–S279. doi: 10.1513/AnnalsATS.201704-337OT
![]() |
[15] |
Fan E, Del SL, Goligher EC, et al. (2017) An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 195: 1253–1263. doi: 10.1164/rccm.201703-0548ST
![]() |
[16] |
Lang JD, Chumley P, Eiserich JP, et al. (2000) Hypercapnia induces injury to alveolar epithelial cells via a nitric oxide-dependent pathway. Am J Physiol Lung Cell Mol Physiol 279: 994–1002. doi: 10.1152/ajplung.2000.279.5.L994
![]() |
[17] |
Morimont P, Batchinsky A, Lambermont B (2015) Update on the role of extracorporeal CO 2 removal as an adjunct to mechanical ventilation in ARDS. Crit Care 19: 117. doi: 10.1186/s13054-015-0799-7
![]() |
[18] | Repessé X, Vieillardbaron A (2017) Hypercapnia during acute respiratory distress syndrome: The tree that hides the forest! J Thorac Dis 9: 1420–1425. |
[19] |
Nin N, Muriel A, Penuelas O, et al. (2017) Severe hypercapnia and outcome of mechanically ventilated patients with moderate or severe acute respiratory distress syndrome. Intensive Care Med 43: 200–208. doi: 10.1007/s00134-016-4611-1
![]() |
[20] | Barnes T, Zochios V, Parhar K (2017) Re-examining permissive hypercapnia in ARDS: A narrative review. Chest. |
[21] | Sahetya SK, Goligher EC, Brower RG (2017) Fifty Years of Research in ARDS. Setting Positive End-Expiratory Pressure in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 195: 1429–1438. |
[22] |
Brower RG, Lanken PN, MacIntyre N, et al. (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351: 327–336. doi: 10.1056/NEJMoa032193
![]() |
[23] |
Meade MO, Cook DJ, Guyatt GH, et al. (2008) Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: A randomized controlled trial. JAMA 299: 637–645. doi: 10.1001/jama.299.6.637
![]() |
[24] |
Mercat A, Richard JC, Vielle B, et al. (2008) Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: A randomized controlled trial. JAMA 299: 646–655. doi: 10.1001/jama.299.6.646
![]() |
[25] | Santa CR, Rojas JI, Nervi R, et al. (2013) High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 6: CD009098. |
[26] |
Talmor D, Sarge T, Malhotra A, et al. (2008) Mechanical ventilation guided by esophageal pressure in acute lung injury. N Engl J Med 359: 2095–2104. doi: 10.1056/NEJMoa0708638
![]() |
[27] |
Fish E, Novack V, Bannergoodspeed VM, et al. (2014) The Esophageal Pressure-Guided Ventilation 2 (EPVent2) trial protocol: A multicentre, randomised clinical trial of mechanical ventilation guided by transpulmonary pressure. BMJ Open 4: e006356. doi: 10.1136/bmjopen-2014-006356
![]() |
[28] |
Kacmarek RM, Villar J, Sulemanji D, et al. (2016) Open Lung Approach for the Acute Respiratory Distress Syndrome: A Pilot, Randomized Controlled Trial. Crit Care Med 44: 32–42. doi: 10.1097/CCM.0000000000001383
![]() |
[29] | Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial I, Cavalcanti AB, Suzumura EA, et al. (2017) Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs. Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA 318: 1335–1345. |
[30] |
Luecke T, Corradi F, Pelosi P (2012) Lung imaging for titration of mechanical ventilation. Curr Opin Anaesthesiol 25: 131–140. doi: 10.1097/ACO.0b013e32835003fb
![]() |
[31] |
Jabaudon M, Godet T, Futier E, et al. (2017) Rationale, study design and analysis plan of the lung imaging morphology for ventilator settings in acute respiratory distress syndrome study (LIVE study): Study protocol for a randomised controlled trial. Anaesthesia Crit Care Pain Med 36: 301–306. doi: 10.1016/j.accpm.2017.02.006
![]() |
[32] |
Bugedo G, Retamal J, Bruhn A (2017) Driving pressure: A marker of severity, a safety limit, or a goal for mechanical ventilation? Crit Care 21: 199. doi: 10.1186/s13054-017-1779-x
![]() |
[33] |
Amato MB, Meade MO, Slutsky AS, et al. (2015) Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 372: 747–755. doi: 10.1056/NEJMsa1410639
![]() |
[34] |
Estenssoro E, Dubin A, Laffaire E, et al. (2002) Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome. Crit Care Med 30: 2450–2456. doi: 10.1097/00003246-200211000-00008
![]() |
[35] |
Papazian L, Forel JM, Gacouin A, et al. (2010) Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 363: 1107–1116. doi: 10.1056/NEJMoa1005372
![]() |
[36] |
Guerin C, Reignier J, Richard JC, et al. (2013) Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 368: 2159–2168. doi: 10.1056/NEJMoa1214103
![]() |
[37] |
Kassis EB, Loring SH, Talmor D (2016) Mortality and pulmonary mechanics in relation to respiratory system and transpulmonary driving pressures in ARDS. Intensive Care Med 42: 1206–1213. doi: 10.1007/s00134-016-4403-7
![]() |
[38] |
Ferguson ND, Cook DJ, Guyatt GH, et al. (2013) High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med 368: 795–805. doi: 10.1056/NEJMoa1215554
![]() |
[39] |
Young D, Lamb SE, Shah S, et al. (2013) High-frequency oscillation for acute respiratory distress syndrome. N Engl J Med 368: 806–813. doi: 10.1056/NEJMoa1215716
![]() |
[40] |
Davies SW, Leonard KL, Falls RK, et al. (2015) Lung protective ventilation (ARDSNet) versus airway pressure release ventilation: Ventilatory management in a combined model of acute lung and brain injury. Trauma Acute Care Surg 78: 240–249. doi: 10.1097/TA.0000000000000518
![]() |
[41] |
Mireles-Cabodevila E, Kacmarek RM (2016) Should Airway Pressure Release Ventilation Be the Primary Mode in ARDS? Respir Care 61: 761–773. doi: 10.4187/respcare.04653
![]() |
[42] |
Zhou Y, Jin X, Lv Y, et al. (2017) Early application of airway pressure release ventilation may reduce the duration of mechanical ventilation in acute respiratory distress syndrome. Intensive Care Med 43: 1648–1659. doi: 10.1007/s00134-017-4912-z
![]() |
[43] |
Bellani G, Laffey JG, Pham T, et al. (2017) Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome. Insights from the LUNG SAFE Study. Am J Respir Crit Care Med 195: 67–77. doi: 10.1164/rccm.201606-1306OC
![]() |
[44] | Patel BK, Wolfe KS, Pohlman AS, et al. (2016) Effect of Noninvasive Ventilation Delivered by Helmet vs. Face Mask on the Rate of Endotracheal Intubation in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. JAMA 315: 2435–2441. |
[45] |
Hernandez G, Roca O, Colinas L (2017) High-flow nasal cannula support therapy: New insights and improving performance. Crit Care 21: 62. doi: 10.1186/s13054-017-1640-2
![]() |
[46] |
Parke RL, Mcguinness SP (2013) Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle. Respir Care 58: 1621–1624. doi: 10.4187/respcare.02358
![]() |
[47] | Drake MG (2017) High Flow Nasal Cannula Oxygen in Adults: An Evidence-Based Assessment. Ann Am Thorac Soc 15: 145–155. |
[48] |
Frat JP, Thille AW, Mercat A, et al. (2015) High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 372: 2185–2196. doi: 10.1056/NEJMoa1503326
![]() |
[49] |
Kang BJ, Koh Y, Lim CM, et al. (2015) Failure of high-flow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med 41: 623–632. doi: 10.1007/s00134-015-3693-5
![]() |
[50] | Ni YN, Luo J, Yu H, et al. (2017) Can High-flow Nasal Cannula Reduce the Rate of Endotracheal Intubation in Adult Patients With Acute Respiratory Failure Compared With Conventional Oxygen Therapy and Noninvasive Positive Pressure Ventilation?: A Systematic Review and Meta-analysis. Chest 151: 764–775. |
[51] |
Marik PE, Kaufman D (1996) The effects of neuromuscular paralysis on systemic and splanchnic oxygen utilization in mechanically ventilated patients. Chest 109: 1038–1042. doi: 10.1378/chest.109.4.1038
![]() |
[52] |
Kaisers U, Busch T, Deja M, et al. (2003) Selective pulmonary vasodilation in acute respiratory distress syndrome. Crit Care Med 31: S337–S342. doi: 10.1097/01.CCM.0000057913.45273.1A
![]() |
[53] |
Griffiths MJ, Evans TW (2005) Inhaled nitric oxide therapy in adults. N Engl J Med 353: 2683–2695. doi: 10.1056/NEJMra051884
![]() |
[54] |
Markewitz BA, Michael JR (2000) Inhaled nitric oxide in adults with the acute respiratory distress syndrome. Respir Med 94: 1023–1028. doi: 10.1053/rmed.2000.0928
![]() |
[55] | Gebistorf F, Karam O, Wetterslev J, et al. (2016) Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults. Cochrane Database Syst Rev 6: CD002787. |
[56] |
Fuller BM, Mohr NM, Skrupky L, et al. (2015) The use of inhaled prostaglandins in patients with ARDS: A systematic review and meta-analysis. Chest 147: 1510–1522. doi: 10.1378/chest.14-3161
![]() |
[57] |
Bassford CR, Thickett DR, Perkins GD (2012) The rise and fall of beta-agonists in the treatment of ARDS. Crit Care 16: 208. doi: 10.1186/cc11221
![]() |
[58] |
National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Matthay MA, et al. (2011) Randomized, placebo-controlled clinical trial of an aerosolized beta(2)-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 184: 561–568. doi: 10.1164/rccm.201012-2090OC
![]() |
[59] |
Gao SF, Perkins GD, Gates S, et al. (2012) Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): A multicentre, randomised controlled trial. Lancet 379: 229–235. doi: 10.1016/S0140-6736(11)61623-1
![]() |
[60] |
Lai-Fook SJ, Rodarte JR (1991) Pleural pressure distribution and its relationship to lung volume and interstitial pressure. J Appl Physiol 70: 967–978. doi: 10.1152/jappl.1991.70.3.967
![]() |
[61] |
Pelosi P, D'Andrea L, Vitale G, et al. (1994) Vertical gradient of regional lung inflation in adult respiratory distress syndrome. Am J Respir Crit Care Med 149: 8–13. doi: 10.1164/ajrccm.149.1.8111603
![]() |
[62] |
Tawhai MH, Nash MP, Lin CL, et al. (2009) Supine and prone differences in regional lung density and pleural pressure gradients in the human lung with constant shape. J Appl Physiol 107: 912–920. doi: 10.1152/japplphysiol.00324.2009
![]() |
[63] |
Malbouisson LM, Busch CJ, Puybasset L, et al. (2000) Role of the heart in the loss of aeration characterizing lower lobes in acute respiratory distress syndrome. CT Scan ARDS Study Group. Am J Respir Crit Care Med 161: 2005–2012. doi: 10.1164/ajrccm.161.6.9907067
![]() |
[64] |
Scholten EL, Beitler JR, Prisk GK, et al. (2017) Treatment of ARDS With Prone Positioning. Chest 151: 215–224. doi: 10.1016/j.chest.2016.06.032
![]() |
[65] |
Mutoh T, Guest RJ, Lamm WJ, et al. (1992) Prone position alters the effect of volume overload on regional pleural pressures and improves hypoxemia in pigs in vivo. Am Rev Respir Dis 146: 300–306. doi: 10.1164/ajrccm/146.2.300
![]() |
[66] |
Lamm WJ, Graham MM, Albert RK (1994) Mechanism by which the prone position improves oxygenation in acute lung injury. Am J Respir Crit Care Med 150: 184–193. doi: 10.1164/ajrccm.150.1.8025748
![]() |
[67] | Munshi L, Del LS, Adhikari N, et al. (2017) Prone Position for Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis. Ann Am Thorac Soc 14: S280–S288. |
[68] |
Peek GJ, Mugford M, Tiruvoipati R, et al. (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial. Lancet 374: 1351–1363. doi: 10.1016/S0140-6736(09)61069-2
![]() |
[69] |
Dembinski R, Hochhausen N, Terbeck S, et al. (2007) Pumpless extracorporeal lung assist for protective mechanical ventilation in experimental lung injury. Crit Care Med 35: 2359–2366. doi: 10.1097/01.CCM.0000281857.87354.A5
![]() |
[70] |
Schmidt M, Stewart C, Bailey M, et al. (2015) Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome: A retrospective international multicenter study. Crit Care Med 43: 654–664. doi: 10.1097/CCM.0000000000000753
![]() |
[71] |
Neto AS, Schmidt M, Azevedo LCP, et al. (2016) Associations between ventilator settings during extracorporeal membrane oxygenation for refractory hypoxemia and outcome in patients with acute respiratory distress syndrome: A pooled individual patient data analysis: Mechanical ventilation during ECMO. Intensive Care Med 42: 1672–1684. doi: 10.1007/s00134-016-4507-0
![]() |
[72] |
Tillmann BW, Klingel ML, Iansavichene AE, et al. (2017) Extracorporeal membrane oxygenation (ECMO) as a treatment strategy for severe acute respiratory distress syndrome (ARDS) in the low tidal volume era: A systematic review. J Crit Care 41: 64–71. doi: 10.1016/j.jcrc.2017.04.041
![]() |
[73] |
Bizzarro MJ, Conrad SA, Kaufman DA, et al. (2011) Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatr Crit Care Med 12: 277–281. doi: 10.1097/PCC.0b013e3181e28894
![]() |
[74] |
Paden ML, Conrad SA, Rycus PT, et al. (2013) Extracorporeal Life Support Organization Registry Report 2012. ASAIO J 59: 202–210. doi: 10.1097/MAT.0b013e3182904a52
![]() |
[75] | Mishra V, Svennevig JL, Bugge JF, et al. (2010) Cost of extracorporeal membrane oxygenation: Evidence from the Rikshospitalet University Hospital, Oslo, Norway. Eur J Cardiothorac Surg 37: 339–342. |
[76] |
Muller T, Lubnow M, Philipp A, et al. (2009) Extracorporeal pumpless interventional lung assist in clinical practice: Determinants of efficacy. Eur Respir J 33: 551–558. doi: 10.1183/09031936.00123608
![]() |
[77] |
Bein T, Aubron C, Papazian L (2017) Focus on ECMO and ECCO2R in ARDS patients. Intensive Care Med 43: 1424–1426. doi: 10.1007/s00134-017-4882-1
![]() |
[78] |
Bein T, Weber-Carstens S, Goldmann A, et al. (2013) Lower tidal volume strategy (approximately 3 ml/kg) combined with extracorporeal CO2 removal versus "conventional" protective ventilation (6 ml/kg) in severe ARDS: The prospective randomized Xtravent-study. Intensive Care Med 39: 847–856. doi: 10.1007/s00134-012-2787-6
![]() |
[79] |
Fitzgerald M, Millar J, Blackwood B, et al. (2014) Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: A systematic review. Crit Care 18: 222. doi: 10.1186/cc13875
![]() |
[80] |
Calfee CS, Delucchi K, Parsons PE, et al. (2014) Subphenotypes in acute respiratory distress syndrome: Latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2: 611–620. doi: 10.1016/S2213-2600(14)70097-9
![]() |
[81] | Famous KR, Delucchi K, Ware LB, et al. (2017) Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy. Am J Respir Crit Care Med 195: 331–338. |
[82] |
Hough CL (2014) Steroids for acute respiratory distress syndrome? Clin Chest Med 35: 781–795. doi: 10.1016/j.ccm.2014.08.014
![]() |
[83] |
Meduri GU, Bridges L, Shih MC, et al. (2016) Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: Analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature. Intensive Care Med 42: 829–840. doi: 10.1007/s00134-015-4095-4
![]() |
[84] | Network TA (2000) Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: A randomized controlled trial. The ARDS Network. JAMA 283: 1995–2002. |
[85] |
Xiong B, Wang C, Tan J, et al. (2016) Statins for the prevention and treatment of acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis. Respirology 21: 1026–1033. doi: 10.1111/resp.12820
![]() |
[86] |
Sabater J, Masclans JR, Sacanell J, et al. (2008) Effects on hemodynamics and gas exchange of omega-3 fatty acid-enriched lipid emulsion in acute respiratory distress syndrome (ARDS): A prospective, randomized, double-blind, parallel group study. Lipids Health Dis 7: 39. doi: 10.1186/1476-511X-7-39
![]() |
[87] |
Raghavendran K, Willson D, Notter RH (2011) Surfactant therapy for acute lung injury and acute respiratory distress syndrome. Crit Care Clin 27: 525–559. doi: 10.1016/j.ccc.2011.04.005
![]() |
[88] |
Shah FA, Girard TD, Yende S (2017) Limiting sedation for patients with acute respiratory distress syndrome-time to wake up. Curr Opin Crit Care 23: 45–51. doi: 10.1097/MCC.0000000000000382
![]() |
[89] |
National Heart L, Wheeler AP, Wiedemann HP, et al. (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354: 2564–2575. doi: 10.1056/NEJMoa062200
![]() |
[90] |
Jozwiak M, Silva S, Persichini R, et al. (2013) Extravascular lung water is an independent prognostic factor in patients with acute respiratory distress syndrome. Crit Care Med 41: 472–480. doi: 10.1097/CCM.0b013e31826ab377
![]() |
[91] |
Krzak A, Pleva M, Napolitano LM (2011) Nutrition therapy for ALI and ARDS. Crit Care Clin 27: 647–659. doi: 10.1016/j.ccc.2011.05.004
![]() |
[92] |
Investigators NS, Finfer S, Chittock DR, et al. (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360: 1283–1297. doi: 10.1056/NEJMoa0810625
![]() |
[93] |
Kortebein P (2009) Rehabilitation for hospital-associated deconditioning. Am J Phys Med Rehabil 88: 66–77. doi: 10.1097/PHM.0b013e3181838f70
![]() |
[94] |
Bailey P, Thomsen GE, Spuhler VJ, et al. (2007) Early activity is feasible and safe in respiratory failure patients. Crit Care Med 35: 139–145. doi: 10.1097/01.CCM.0000251130.69568.87
![]() |
[95] |
Morris PE, Berry MJ, Files DC, et al. (2016) Standardized Rehabilitation and Hospital Length of Stay Among Patients With Acute Respiratory Failure: A Randomized Clinical Trial. JAMA 315: 2694–2702. doi: 10.1001/jama.2016.7201
![]() |
[96] | Jabaudon M, Blondonnet R, Audard J, et al. (2017) Recent directions in personalised acute respiratory distress syndrome medicine. Anaesth Crit Care Pain Med. |
[97] | Shankar-Hari M, Mcauley DF (2017) Acute Respiratory Distress Syndrome Phenotypes and Identifying Treatable Traits. The Dawn of Personalized Medicine for ARDS. Am J Respir Crit Care Med 195: 280–281. |
[98] |
Wilson JG, Liu KD, Zhuo H, et al. (2015) Mesenchymal stem (stromal) cells for treatment of ARDS: A phase 1 clinical trial. Lancet Respir Med 3: 24–32. doi: 10.1016/S2213-2600(14)70291-7
![]() |
[99] | Laffey JG, Matthay MA (2017) Fifty Years of Research in ARDS. Cell-based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value. Am J Respir Crit Care Med 196: 266–273. |
1. | Raya Bushkalova, Maylis Farno, Christophe Tenailleau, Benjamin Duployer, Daniel Cussac, Angelo Parini, Brigitte Sallerin, Sophie Girod Fullana, Alginate-chitosan PEC scaffolds: A useful tool for soft tissues cell therapy, 2019, 571, 03785173, 118692, 10.1016/j.ijpharm.2019.118692 | |
2. | Matteo Cibinel, Giorgia Pugliese, Davide Porrelli, Lucia Marsich, Vanni Lughi, Recycling alginate composites for thermal insulation, 2021, 251, 01448617, 116995, 10.1016/j.carbpol.2020.116995 | |
3. | Ravindra V. Badhe, Sonali S. Nipate, 2020, 9781119640196, 259, 10.1002/9781119640240.ch10 | |
4. | Sara Lee, Kangwon Lee, pH-Sensitive Folic Acid Conjugated Alginate Nanoparticle for Induction of Cancer-Specific Fluorescence Imaging, 2020, 12, 1999-4923, 537, 10.3390/pharmaceutics12060537 | |
5. | O. Guaresti, C. García–Astrain, R.H. Aguirresarobe, A. Eceiza, N. Gabilondo, Synthesis of stimuli–responsive chitosan–based hydrogels by Diels–Alder cross–linking `click´ reaction as potential carriers for drug administration, 2018, 183, 01448617, 278, 10.1016/j.carbpol.2017.12.034 | |
6. | Paula Camacho, Hafiz Busari, Kelly B. Seims, John W. Tolbert, Lesley W. Chow, 2019, Chapter 2, 978-3-030-23905-3, 67, 10.1007/978-3-030-23906-0_2 | |
7. | Heidrun Steinle, Tudor-Mihai Ionescu, Selina Schenk, Sonia Golombek, Silju-John Kunnakattu, Melek Tutku Özbek, Christian Schlensak, Hans Peter Wendel, Meltem Avci-Adali, Incorporation of Synthetic mRNA in Injectable Chitosan-Alginate Hybrid Hydrogels for Local and Sustained Expression of Exogenous Proteins in Cells, 2018, 19, 1422-0067, 1313, 10.3390/ijms19051313 | |
8. | Janeni Natarajan, Giridhar Madras, Kaushik Chatterjee, Tailoring the degradation rate and release kinetics from poly(galactitol sebacate) by blending with chitosan, alginate or ethyl cellulose, 2016, 93, 01418130, 1591, 10.1016/j.ijbiomac.2016.02.039 | |
9. | Dorota Bociaga, Mateusz Bartniak, Jacek Grabarczyk, Karolina Przybyszewska, Sodium Alginate/Gelatine Hydrogels for Direct Bioprinting—The Effect of Composition Selection and Applied Solvents on the Bioink Properties, 2019, 12, 1996-1944, 2669, 10.3390/ma12172669 | |
10. | Md Saquib Hasnain, Amit Kumar Nayak, Mallesh Kurakula, Mohammad Niyaz Hoda, 2020, 9780128176405, 129, 10.1016/B978-0-12-817640-5.00006-6 | |
11. | V. Guarino, M. D’Albore, R. Altobelli, L. Ambrosio, Polymer Bioprocessing to Fabricate 3D Scaffolds for Tissue Engineering, 2016, 31, 2195-8602, 587, 10.3139/217.3239 | |
12. | Robin Wanka, Julian Koc, Jessica Clarke, Kelli Z. Hunsucker, Geoffrey W. Swain, Nick Aldred, John A. Finlay, Anthony S. Clare, Axel Rosenhahn, Sol–Gel-Based Hybrid Materials as Antifouling and Fouling-Release Coatings for Marine Applications, 2020, 12, 1944-8244, 53286, 10.1021/acsami.0c15288 | |
13. | Irene Bonadies, Francesca Cimino, Vincenzo Guarino, In vitrodegradation of zein nanofibres for propolis release in oral treatments, 2019, 6, 2053-1591, 075407, 10.1088/2053-1591/ab178e | |
14. | Diana Larisa Roman, Vasile Ostafe, Adriana Isvoran, Deeper inside the specificity of lysozyme when degrading chitosan. A structural bioinformatics study, 2020, 100, 10933263, 107676, 10.1016/j.jmgm.2020.107676 | |
15. | Xiaolin Zhang, Chen Huang, Yi Zhao, Xiangyu Jin, Ampicillin-incorporated alginate-chitosan fibers from microfluidic spinning and for vitro release, 2017, 28, 0920-5063, 1408, 10.1080/09205063.2017.1329914 | |
16. | Vincenzo Guarino, Tania Caputo, Paola Calcagnile, Rosaria Altobelli, Christian Demitri, Luigi Ambrosio, Core/shell cellulose-based microspheres for oral administration of Ketoprofen Lysinate, 2018, 106, 15524973, 2636, 10.1002/jbm.b.34080 | |
17. | Maria Dul, Krzysztof J. Paluch, Anne Marie Healy, Astrid Sasse, Lidia Tajber, Optimisation of the self-assembly process: production of stable, alginate-based polyelectrolyte nanocomplexes with protamine, 2017, 19, 1388-0764, 10.1007/s11051-017-3901-z | |
18. | Djurdja Vukajlovic, Julie Parker, Oana Bretcanu, Katarina Novakovic, Chitosan based polymer/bioglass composites for tissue engineering applications, 2019, 96, 09284931, 955, 10.1016/j.msec.2018.12.026 | |
19. | Xin Bai, Mingzhu Gao, Sahla Syed, Jerry Zhuang, Xiaoyang Xu, Xue-Qing Zhang, Bioactive hydrogels for bone regeneration, 2018, 3, 2452199X, 401, 10.1016/j.bioactmat.2018.05.006 | |
20. | Sung-Wook Yoon, Myong-Ji Kim, Kyeong-Won Paeng, Kyeong Ae Yu, Chong-Kil Lee, Young Woo Song, Jae-Kook Cha, Mariano Sanz, Ui-Won Jung, Locally Applied Slow-Release of Minocycline Microspheres in the Treatment of Peri-Implant Mucositis: An Experimental In Vivo Study, 2020, 12, 1999-4923, 668, 10.3390/pharmaceutics12070668 | |
21. | Maryam Eshrati, Federico Amadei, Tom Van de Wiele, Mariam Veschgini, Stefan Kaufmann, Motomu Tanaka, Biopolymer-Based Minimal Formulations Boost Viability and Metabolic Functionality of Probiotics Lactobacillus rhamnosus GG through Gastrointestinal Passage, 2018, 34, 0743-7463, 11167, 10.1021/acs.langmuir.8b01915 | |
22. | Ahmed Salama, Ragab E. Abou-Zeid, Iriczalli Cruz-Maya, Vincenzo Guarino, Mineralized nanocomposite scaffolds based on soy protein grafted oxidized cellulose for biomedical applications, 2021, 34, 22147853, 16, 10.1016/j.matpr.2019.12.069 | |
23. | M.S. Gasser, E. El Sherif, H.S. Mekhamer, R.O. Abdel Rahman, Assessment of Cyanex 301 impregnated resin for its potential use to remove cobalt from aqueous solutions, 2020, 185, 00139351, 109402, 10.1016/j.envres.2020.109402 | |
24. | Simona Zuppolini, Iriczalli Cruz Maya, Laura Diodato, Vincenzo Guarino, Anna Borriello, Luigi Ambrosio, Self-associating cellulose-graft-poly(ε-caprolactone) to design nanoparticles for drug release, 2020, 108, 09284931, 110385, 10.1016/j.msec.2019.110385 | |
25. | Irudayaraj Rajendran, 2020, 9781119143772, 1195, 10.1002/9781119143802.ch49 | |
26. | Clara López-Iglesias, Alba M. Casielles, Ayça Altay, Ruggero Bettini, Carmen Alvarez-Lorenzo, Carlos A. García-González, From the printer to the lungs: Inkjet-printed aerogel particles for pulmonary delivery, 2019, 357, 13858947, 559, 10.1016/j.cej.2018.09.159 | |
27. | Vincenzo Guarino, Michele Iafisco, Silvia Spriano, 2020, 9780081025949, 1, 10.1016/B978-0-08-102594-9.00001-2 | |
28. | Wan Nur Syahirah, Nor Azura Azami, Kai-Hee Huong, A. A. Amirul, Preparation, characterization and biodegradation of blend films of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) with natural biopolymers, 2020, 0170-0839, 10.1007/s00289-020-03286-1 | |
29. | Bhavika B. Patel, Marilyn C. McNamara, Laura S. Pesquera-Colom, Emily M. Kozik, Jasmin Okuzonu, Nicole N. Hashemi, Donald S. Sakaguchi, Recovery of Encapsulated Adult Neural Progenitor Cells from Microfluidic-Spun Hydrogel Fibers Enhances Proliferation and Neuronal Differentiation, 2020, 5, 2470-1343, 7910, 10.1021/acsomega.9b04214 | |
30. | Ahmed Salama, Ragab E. Abou-Zeid, Iriczalli Cruz-Maya, Vincenzo Guarino, Soy protein hydrolysate grafted cellulose nanofibrils with bioactive signals for bone repair and regeneration, 2020, 229, 01448617, 115472, 10.1016/j.carbpol.2019.115472 | |
31. | Sajana Manandhar, Erica Sjöholm, Johan Bobacka, Jessica M. Rosenholm, Kuldeep K. Bansal, Polymer-Drug Conjugates as Nanotheranostic Agents, 2021, 2, 2624-845X, 63, 10.3390/jnt2010005 | |
32. | Daniel Hernandez-Patlan, Bruno Solis-Cruz, Mario Alberto Cano-Vega, Eric Beyssac, Ghislain Garrait, Xochitl Hernandez-Velasco, Raquel Lopez-Arellano, Guillermo Tellez, Gustavo R. Rivera-Rodriguez, Development of Chitosan and Alginate Nanocapsules to Increase the Solubility, Permeability and Stability of Curcumin, 2019, 14, 1872-5120, 132, 10.1007/s12247-018-9341-1 | |
33. | Davide Porrelli, Andrea Travan, Gianluca Turco, Matteo Crosera, Massimiliano Borgogna, Ivan Donati, Sergio Paoletti, Gianpiero Adami, Eleonora Marsich, Antibacterial‐nanocomposite bone filler based on silver nanoparticles and polysaccharides, 2018, 12, 1932-6254, 10.1002/term.2365 | |
34. | Xiaolin Zhang, Chen Huang, Xiangyu Jin, Influence of K+and Na+ions on the degradation of wet-spun alginate fibers for tissue engineering, 2017, 134, 00218995, 10.1002/app.44396 | |
35. | Shreya Agrawal, Rohit Srivastava, 2020, Chapter 15, 978-3-030-34470-2, 355, 10.1007/978-3-030-34471-9_15 | |
36. | Shadpour Mallakpour, Leila khodadadzadeh, 2020, 9780081022610, 599, 10.1016/B978-0-08-101903-0.00015-5 | |
37. | Nahid OSMAN, Tasneem SULİMAN, Khadega OSMAN, Characterization of Native Alginates of Common Alginophytes from the Red Sea Coast of Sudan, 2020, 2148-6905, 266, 10.21448/ijsm.685864 | |
38. | Mónica Cristina García, María Laura Guzman, Martín A. Himelfarb, Nicolás J. Litterio, María Eugenia Olivera, Alvaro Jimenez-Kairuz, Preclinical pharmacokinetics of benznidazole-loaded interpolyelectrolyte complex-based delivery systems, 2018, 122, 09280987, 281, 10.1016/j.ejps.2018.07.005 | |
39. | E. Massarelli, D. Silva, A.F.R. Pimenta, A.I. Fernandes, J.L.G. Mata, H. Armês, M. Salema-Oom, B. Saramago, A.P. Serro, Polyvinyl alcohol/chitosan wound dressings loaded with antiseptics, 2021, 593, 03785173, 120110, 10.1016/j.ijpharm.2020.120110 | |
40. | N. M. J. Rasali, Y. Nagao, A. S. Samsudin, Enhancement on amorphous phase in solid biopolymer electrolyte based alginate doped NH4NO3, 2019, 25, 0947-7047, 641, 10.1007/s11581-018-2667-3 | |
41. | Lucie Bacakova, Julia Pajorova, Marketa Zikmundova, Elena Filova, Petr Mikes, Vera Jencova, Eva Kuzelova Kostakova, Alla Sinica, 2020, Chapter 5, 978-1-78985-869-3, 10.5772/intechopen.88602 | |
42. | H. Agusnar, B. Wirjosentono, T. Rihayat, Z. Salisah, Synthesis and characterization of poly (lactic acid)/chitosan nanocomposites based on renewable resources as biobased-material, 2018, 953, 1742-6588, 012015, 10.1088/1742-6596/953/1/012015 | |
43. | Soyon Kim, Jiabing Fan, Chung-Sung Lee, Min Lee, Dual Functional Lysozyme–Chitosan Conjugate for Tunable Degradation and Antibacterial Activity, 2020, 3, 2576-6422, 2334, 10.1021/acsabm.0c00087 | |
44. | Yu Han, Xiaofei Xu, Fengxia Liu, Wei Wei, Zhijun Liu, Study of the theory of microbubble bursting to obtain bio-inspired alginate nanoparticles, 2020, 591, 09277757, 124494, 10.1016/j.colsurfa.2020.124494 | |
45. | Julia Anna Semba, Adam Aron Mieloch, Jakub Dalibor Rybka, Introduction to the state-of-the-art 3D bioprinting methods, design, and applications in orthopedics, 2020, 18, 24058866, e00070, 10.1016/j.bprint.2019.e00070 | |
46. | Samson Afewerki, Amir Sheikhi, Soundarapandian Kannan, Samad Ahadian, Ali Khademhosseini, Gelatin-polysaccharide composite scaffolds for 3D cell culture and tissue engineering: Towards natural therapeutics, 2019, 4, 23806761, 96, 10.1002/btm2.10124 | |
47. | Ingrid Brezaniova, Jiri Trousil, Zulfiya Cernochova, Vladimir Kral, Martin Hruby, Petr Stepanek, Miroslav Slouf, Self-assembled chitosan-alginate polyplex nanoparticles containing temoporfin, 2017, 295, 0303-402X, 1259, 10.1007/s00396-016-3992-6 | |
48. | Teuku Rihayat, Januar Parlaungan Siregar, Alfian Putra, Zahra Fona, Shafira Riskina, Wildan Syahputra, Jamiluddin Jaafar, Wound Dressing Based on Banana Peels Waste and Chitosan by Strengthening Lignin as Wound Healing Medicine, 2019, 506, 1757-899X, 012056, 10.1088/1757-899X/506/1/012056 | |
49. | Aditi Bhattacharyya, Debarati Mukherjee, Roshnara Mishra, P.P. Kundu, Preparation of polyurethane–alginate/chitosan core shell nanoparticles for the purpose of oral insulin delivery, 2017, 92, 00143057, 294, 10.1016/j.eurpolymj.2017.05.015 | |
50. | V. Balan, S. Malihin, Liliana Verestiuc, 2019, Chapter 12, 978-981-15-0262-0, 343, 10.1007/978-981-15-0263-7_12 | |
51. | Kláudia Maria Machado Neves Silva, Bruna Lopes Costa, Lays Fernanda Dourado, Rummenigge Oliveira Silva, Armando Silva‐Cunha, Anderson Kenedy Santos, Rodrigo Ribeiro Resende, Paulo Eustáquio Faria, Juan Carlos Campos Rubio, Gisele Assis Castro Goulart, Priscila Pereira Silva‐Caldeira, Four modified sodium alginate/carboxymethylcellulose blends for prednisone delivery, 2021, 138, 0021-8995, 50383, 10.1002/app.50383 | |
52. | Duarte Nuno Carvalho, Ana Rita Inácio, Rita O. Sousa, Rui L. Reis, Tiago H. Silva, 2020, 9780128179437, 543, 10.1016/B978-0-12-817943-7.00019-6 | |
53. | Janeth Serrano-Bello, Iriczalli Cruz-Maya, Fernando Suaste-Olmos, Patricia González-Alva, Rosaria Altobelli, Luigi Ambrosio, Luis Alberto Medina, Vincenzo Guarino, Marco Antonio Alvarez-Perez, In vivo Regeneration of Mineralized Bone Tissue in Anisotropic Biomimetic Sponges, 2020, 8, 2296-4185, 10.3389/fbioe.2020.00587 | |
54. | Tania Mariastella Caputo, Anna Aliberti, Angela Maria Cusano, Menotti Ruvo, Antonello Cutolo, Andrea Cusano, Stimuli‐responsive hybrid microgels for controlled drug delivery: Sorafenib as a model drug, 2021, 138, 0021-8995, 50147, 10.1002/app.50147 | |
55. | Fernanda Carla Bombaldi de Souza, Renata Francielle Bombaldi de Souza, Bernard Drouin, Diego Mantovani, Ângela Maria Moraes, Comparative study on complexes formed by chitosan and different polyanions: Potential of chitosan-pectin biomaterials as scaffolds in tissue engineering, 2019, 132, 01418130, 178, 10.1016/j.ijbiomac.2019.03.187 | |
56. | Iriczalli Cruz‐Maya, Rosaria Altobelli, Marica Marrese, Vincenzo Guarino, Design of alginate based micro‐gels via electro fluid dynamics to construct microphysiological cell culture systems, 2021, 1042-7147, 10.1002/pat.5310 | |
57. | Young Kook Kim, Se-Na Kim, Chang Hee Min, Min Park, Dai Woo Kim, Ahnul Ha, Yu Jeong Kim, Young Bin Choy, Ki Ho Park, Novel glaucoma model in rats using photo-crosslinked azidobenzoic acid-modified chitosan, 2021, 125, 09284931, 112112, 10.1016/j.msec.2021.112112 | |
58. | R. Abhinandan, S. Pranav Adithya, D. Saleth Sidharthan, K. Balagangadharan, N. Selvamurugan, Synthesis and characterization of magnesium diboride nanosheets in alginate/polyvinyl alcohol scaffolds for bone tissue engineering, 2021, 203, 09277765, 111771, 10.1016/j.colsurfb.2021.111771 | |
59. | Farzad Seidi, Mohsen Khodadadi Yazdi, Maryam Jouyandeh, Midhun Dominic, Haleh Naeim, Mojtaba Nasiri Nezhad, Babak Bagheri, Sajjad Habibzadeh, Payam Zarrintaj, Mohammad Reza Saeb, Masoud Mozafari, Chitosan-based blends for biomedical applications, 2021, 01418130, 10.1016/j.ijbiomac.2021.05.003 | |
60. | Dania Adila Ahmad Ruzaidi, Mohd Muzamir Mahat, Saiful Arifin Shafiee, Zarif Mohamed Sofian, Awis Sukarni Mohmad Sabere, Rosmamuhamadani Ramli, Hazwanee Osman, Hairul Hisham Hamzah, Zaidah Zainal Ariffin, Kishor Kumar Sadasivuni, Advocating Electrically Conductive Scaffolds with Low Immunogenicity for Biomedical Applications: A Review, 2021, 13, 2073-4360, 3395, 10.3390/polym13193395 | |
61. | Piotr Pańtak, Ewelina Cichoń, Joanna Czechowska, Aneta Zima, Influence of Natural Polysaccharides on Properties of the Biomicroconcrete-Type Bioceramics, 2021, 14, 1996-1944, 7496, 10.3390/ma14247496 | |
62. | Iman Sahafnejad‐Mohammadi, Sadegh Rahmati, Najmeh Najmoddin, Mahdi Bodaghi, Biomimetic Polycaprolactone‐Graphene Oxide Composites for 3D Printing Bone Scaffolds, 2023, 1438-7492, 2200558, 10.1002/mame.202200558 | |
63. | Anda-Mihaela Craciun, Liliana Mititelu-Tartau, Gabriela Gavril, Luminita Marin, Chitosan crosslinking with pyridoxal 5-phosphate vitamer toward biocompatible hydrogels for in vivo applications, 2021, 193, 01418130, 1734, 10.1016/j.ijbiomac.2021.10.228 | |
64. | Smaher M. Elbayomi, Haili Wang, Tamer M. Tamer, Yezi You, Enhancement of Antioxidant and Hydrophobic Properties of Alginate via Aromatic Derivatization: Preparation, Characterization, and Evaluation, 2021, 13, 2073-4360, 2575, 10.3390/polym13152575 | |
65. | Davide Porrelli, Martina Gruppuso, Federica Vecchies, Eleonora Marsich, Gianluca Turco, Alginate bone scaffolds coated with a bioactive lactose modified chitosan for human dental pulp stem cells proliferation and differentiation, 2021, 273, 01448617, 118610, 10.1016/j.carbpol.2021.118610 | |
66. | Jyosna Doniparthi, Suryaprakash Reddy Chappidi, E. Bhargav, 2023, Chapter 2, 978-981-19-6936-2, 19, 10.1007/978-981-19-6937-9_2 | |
67. | Christopher R. Farrow, Loong-Tak Lim, Josef D. Ackerman, Environmentally friendly microbeads to model the dispersal of particulates in aquatic systems, 2022, 842, 00489697, 156680, 10.1016/j.scitotenv.2022.156680 | |
68. | Cheng-Tang Pan, Ruei-Siang Yu, Chih-Jung Yang, Lih-Ren Chen, Zhi-Hong Wen, Nai-Yu Chen, Hsin-You Ou, Chun-Yen Yu, Yow-Ling Shiue, Sustained-Release and pH-Adjusted Alginate Microspheres-Encapsulated Doxorubicin Inhibit the Viabilities in Hepatocellular Carcinoma-Derived Cells, 2021, 13, 1999-4923, 1417, 10.3390/pharmaceutics13091417 | |
69. | Hyungtaek Kim, Dahee Song, Hai V. Ngo, Gang Jin, Chulhun Park, Jun-Bom Park, Beom-Jin Lee, Modulation of the clinically accessible gelation time using glucono-d-lactone and pyridoxal 5′-phosphate for long-acting alginate in situ forming gel injectable, 2021, 272, 01448617, 118453, 10.1016/j.carbpol.2021.118453 | |
70. | Wenqing Li, Wei Li, Yulian Wan, Longfeng Wang, Tao Zhou, Preparation, characterization and releasing property of antibacterial nano-capsules composed of ε-PL-EGCG and sodium alginate-chitosan, 2022, 204, 01418130, 652, 10.1016/j.ijbiomac.2022.01.123 | |
71. | Markel Lafuente‐Merchan, Sandra Ruiz‐Alonso, Alaitz Zabala, Patricia Gálvez‐Martín, Juan Antonio Marchal, Blanca Vázquez‐Lasa, Idoia Gallego, Laura Saenz‐del‐Burgo, Jose Luis Pedraz, Chondroitin and Dermatan Sulfate Bioinks for 3D Bioprinting and Cartilage Regeneration, 2022, 22, 1616-5187, 2100435, 10.1002/mabi.202100435 | |
72. | Mohsen Khodarahmi, Hanieh Abbasi, Maryam Kouchak, Masoud Mahdavinia, Somayeh Handali, Nadereh Rahbar, Nanoencapsulation of aptamer-functionalized 5-Fluorouracil liposomes using alginate/chitosan complex as a novel targeting strategy for colon-specific drug delivery, 2022, 71, 17732247, 103299, 10.1016/j.jddst.2022.103299 | |
73. | Nandan Sarkar, Arindam Maity, 2023, 9780128212868, 291, 10.1016/B978-0-12-821286-8.00010-0 | |
74. | Ayla Hassani, Çığır Biray Avci, Sajed Nazif Kerdar, Hassan Amini, Meisam Amini, Mahdi Ahmadi, Shinji Sakai, Bakiye Goker Bagca, Neslihan Pınar Ozates, Reza Rahbarghazi, Ali Baradar Khoshfetrat, Interaction of alginate with nano-hydroxyapatite-collagen using strontium provides suitable osteogenic platform, 2022, 20, 1477-3155, 10.1186/s12951-022-01511-9 | |
75. | Noor Muokhni Ayub, Nur Faeza Abu Kassim, Sumiyyah Sabar, Cameron E. Webb, Kee Zhen Xiang, Nur Aida Hashim, An efficient and biodegradable alginate-gelatin hydrogel beads as bait against Aedes aegypti and Aedes albopictus, 2023, 224, 01418130, 1460, 10.1016/j.ijbiomac.2022.10.233 | |
76. | Parisa Kangari, Leila Roshangar, Aida Iraji, Tahereh Talaei-Khozani, Mahboobeh Razmkhah, Accelerating effect of Shilajit on osteogenic property of adipose-derived mesenchymal stem cells (ASCs), 2022, 17, 1749-799X, 10.1186/s13018-022-03305-z | |
77. | Abina Basanth, Neelaambhigai Mayilswamy, Balasubramanian Kandasubramanian, Bone regeneration by biodegradable polymers, 2022, 61, 2574-0881, 816, 10.1080/25740881.2022.2029886 | |
78. | Josef Daniel Ackerman, Christopher R. Farrow, Loong-Tak Lim, Environmentally Friendly Microbeads to Model the Dispersal of Particulates in Aquatic Systems, 2022, 1556-5068, 10.2139/ssrn.4056004 | |
79. | Mehmet Ali Karaca, Derya Dilek Kancagi, Ugur Ozbek, Ercument Ovali, Ozgul Gok, Preparation of Cell-Loaded Microbeads as Stable and Injectable Delivery Platforms for Tissue Engineering, 2023, 8, 2313-7673, 155, 10.3390/biomimetics8020155 | |
80. | Lakshmanan Muthulakshmi, Shalini Mohan, Nellaiah Hariharan, Jeenat Aslam, 2023, 9781119881360, 365, 10.1002/9781119881391.ch16 | |
81. | Yelsi Listiana Dewi, Ahmad Sofyan, Hendra Herdian, Awistaros Angger Sakti, Agung Irawan, Jasmadi Jasmadi, Ayu Septi Anggraeni, Efri Mardawati, Agus Adriyanto, Maria Endo Mahata, Ulvi Fitri Handayani, Daniel Candido Da Costa Soares, Gomera Bouk, Maria Kristina Sinabang, Harmiansyah Harmiansyah, Processing technology to improve seaweed nutritional quality as a feed for poultry: a review and its implementation, 2024, 80, 0043-9339, 207, 10.1080/00439339.2023.2270952 | |
82. | Elham Rostami, Investigation of Alginate-Chitosan nanoparticles As a Drug Carrier for Levothyroxine, 2024, 19, 1735-7780, 10.5812/jjnpp-150307 | |
83. | H. Carrêlo, M. Jiménez-Rosado, Tânia Vieira, Rafaela R. Da Rosa, Victor M. Perez-Puyana, Jorge Carvalho Silva, A. Romero, J.P. Borges, Paula I.P. Soares, A Thermoresponsive injectable drug delivery system of chitosan/β-glycerophosphate with gellan gum/alginate microparticles, 2024, 271, 01418130, 131981, 10.1016/j.ijbiomac.2024.131981 | |
84. | Narges Johari, Faezeh Rahimi, Haniyeh Azami, Fatemeh Rafati, Zeinab Nokhbedehghan, Ali Samadikuchaksaraei, Lorenzo Moroni, The impact of copper nanoparticles surfactant on the structural and biological properties of chitosan/sodium alginate wound dressings, 2024, 162, 27729508, 213918, 10.1016/j.bioadv.2024.213918 | |
85. | Phool Chandra, Vaibhav Rastogi, Mayur Porwal, Urvashi Saxena, Anurag Verma, Nishat Fatma, Zeeshan Ali, Neetu Sachan, Utilization of Polymers for the Development of Nanomaterials, 2024, 413, 1022-1360, 10.1002/masy.202400068 | |
86. | Abhishesh Kumar Mehata, Chandrasekhar Singh, Ankit Kumar Malik, Aseem Setia, Madaswamy S. Muthu, 2024, Chapter 2, 978-981-99-8825-9, 39, 10.1007/978-981-99-8826-6_2 | |
87. | Henrique Carrêlo, Maria Teresa Cidade, João Paulo Borges, Paula Soares, Gellan Gum/Alginate Microparticles as Drug Delivery Vehicles: DOE Production Optimization and Drug Delivery, 2023, 16, 1424-8247, 1029, 10.3390/ph16071029 | |
88. | Wei-Shu Lin, Jeffrey M. Catchmark, Development of Sustainable Adhesives Based on Polysaccharide–Polyelectrolyte Complexes for Natural Fiber-Based Materials, 2024, 6, 2637-6105, 7947, 10.1021/acsapm.4c00391 | |
89. | Katarzyna Mikula, Grzegorz Izydorczyk, Małgorzata Mironiuk, Daniel Szopa, Katarzyna Chojnacka, Anna Witek-Krowiak, Selection of matrix material for hydrogel carriers of plant micronutrients, 2024, 59, 0022-2461, 3031, 10.1007/s10853-024-09358-1 | |
90. | Jens Risbo, Tommy Nylander, Motomu Tanaka, Delivery of probiotics and enzymes in self-assemblies of lipids and biopolymers based on colloidal principles, 2023, 3, 2813-0499, 10.3389/frsfm.2023.1257688 | |
91. | Rafael Fernandes Pinto da Rocha, Marcia Parente Melo da Costa, Antonio Carlos Augusto da Costa, Ivana Lourenço de Mello Ferreira, Study of the degradation in an ultisol of alginate-chitosan complex and its stability and applicability as a soil conditioner, 2024, 264, 01418130, 130384, 10.1016/j.ijbiomac.2024.130384 | |
92. | Wei‐Shu Lin, Kai Chi, Jeffrey M. Catchmark, Eco‐Friendly Food Packaging Barrier Coatings Comprised of Ball‐Milled Polysaccharide Polyelectrolyte Complexes, 2024, 37, 0894-3214, 1145, 10.1002/pts.2853 | |
93. | Karen Guillén-Carvajal, Benjamín Valdez-Salas, Ernesto Beltrán-Partida, Jorge Salomón-Carlos, Nelson Cheng, Chitosan, Gelatin, and Collagen Hydrogels for Bone Regeneration, 2023, 15, 2073-4360, 2762, 10.3390/polym15132762 | |
94. | Maryam Nazemoroaia, Fatemeh Bagheri, Seyede Zohreh Mirahmadi-Zare, Farshid Eslami-kaliji, Amin Derakhshan, Asymmetric natural wound dressing based on porous chitosan-alginate hydrogel/electrospun PCL-silk sericin loaded by 10-HDA for skin wound healing: In vitro and in vivo studies, 2024, 03785173, 124976, 10.1016/j.ijpharm.2024.124976 | |
95. | Shahrzad Ameli, Moloud Nourani, Nafiseh Bakhshi, Bahareh Salemi, Elham Assadpour, Seid Mahdi Jafari, Alginate-gelatin composite hydrogels for encapsulating Aloe vera extract; optimization, characterization, and release kinetics, 2025, 9, 26668939, 100717, 10.1016/j.carpta.2025.100717 | |
96. | Spotlight on Polyelectrolyte Complexes and Their Medical Application in Drug Delivery, 2025, 25, 2959-183X, 266, 10.32947/ajps.v25i2.1115 |
Chitosan application | References |
Cosmetic | [125] |
Photography | [126] |
Artificially skin | [127] |
Agriculture | [128] |
Food and nutrition | [129] |
Ophthalmology | [130, 131] |
Water engineering | [132] |
Drug delivery | |
- Hydrogel | [133] |
- Tablet | [134] |
- Tablet for controlled release | [135] |
- Microcapsule | [136] |
- Nanocapsule | [137] |
- Beades | [138] |
- Transdermal system | [139] |
Antibacterial agent | [140] |
Blood anti-coagulants | [141] |
Anti-thrombogenic and haemostatic materials | [142] |
Fat trapper | [143] |
Alginate application | References |
Cosmetic | [144] |
Food industry | [145] |
Biofuel | [146] |
Oral vaccination | [147] |
Drug delivery | [148] |
- Hydrogel | [149] |
- Floating beads | [150] |
- wound dressing | [151] |
Implantation of living cells | [152] |
Antihemostatic | [153] |
Hypocholesterolemic | [154] |
Hypoglycemic | [154] |
Anti-hypertension | [155] |
Anti-obesity | [156] |
Antitumoral | [157] |
Prophylaxy of radionuclide intoxication | [158] |
Chitosan application | References |
Cosmetic | [125] |
Photography | [126] |
Artificially skin | [127] |
Agriculture | [128] |
Food and nutrition | [129] |
Ophthalmology | [130, 131] |
Water engineering | [132] |
Drug delivery | |
- Hydrogel | [133] |
- Tablet | [134] |
- Tablet for controlled release | [135] |
- Microcapsule | [136] |
- Nanocapsule | [137] |
- Beades | [138] |
- Transdermal system | [139] |
Antibacterial agent | [140] |
Blood anti-coagulants | [141] |
Anti-thrombogenic and haemostatic materials | [142] |
Fat trapper | [143] |
Alginate application | References |
Cosmetic | [144] |
Food industry | [145] |
Biofuel | [146] |
Oral vaccination | [147] |
Drug delivery | [148] |
- Hydrogel | [149] |
- Floating beads | [150] |
- wound dressing | [151] |
Implantation of living cells | [152] |
Antihemostatic | [153] |
Hypocholesterolemic | [154] |
Hypoglycemic | [154] |
Anti-hypertension | [155] |
Anti-obesity | [156] |
Antitumoral | [157] |
Prophylaxy of radionuclide intoxication | [158] |